Approaches for Performance Verification Toward Standardization of Peripheral Blood Regulatory T-Cell Detection by Flow Cytometry

Mei Liu; Jin-Peng Liu; Pan Wang; Ya-Jing Fu; Min Zhao; Yong-Jun Jiang; Zi-Ning Zhang; Hong Shang

doi:10.5858/arpa.2023-0284-OA

Approaches for Performance Verification Toward Standardization of Peripheral Blood Regulatory T-Cell Detection by Flow Cytometry

Arch Pathol Lab Med. 2024 Feb 22. doi: 10.5858/arpa.2023-0284-OA. Online ahead of print.

Authors

Mei Liu^{1

2}, Jin-Peng Liu^{1

2}, Pan Wang^{1

2}, Ya-Jing Fu^{1

2}, Min Zhao¹, Yong-Jun Jiang^{1

2}, Zi-Ning Zhang^{1

2}, Hong Shang^{1

2}

Affiliations

¹ From NHC Key Laboratory of AIDS Immunology - China Medical University (M Liu, J-P Liu, Wang, Fu, Jiang, Zhang, Shang), National Clinical Research Center for Laboratory Medicine (M Liu, J-P Liu, Wang, Fu, Zhao, Jiang, Zhang, Shang), and the Department of Laboratory Medicine (Zhao, Shang), The First Hospital of China Medical University, Shenyang, China.
² Units of Medical Laboratory (M Liu, J-P Liu, Wang, Fu, Jiang, Zhang, Shang) and Key Laboratory of AIDS Immunology (J-P Liu, Wang, Fu, Jiang, Zhang, Shang), Chinese Academy of Medical Sciences, Shenyang, China.

PMID: 38385871
DOI: 10.5858/arpa.2023-0284-OA

Abstract

Context.—: Regulatory T-cell (Treg) detection in peripheral blood, based on flow cytometry, is invaluable for diagnosis and treatment of immune-mediated diseases. However, there is a lack of reliable methods to verify the performance, which is pivotal towards standardization of the Tregs assay.

Objective.—: To conduct standardization studies and verify the performance of 3 commercially available reagent sets for the Tregs assay based on flow cytometry and agreement analysis for Treg detection across the different reagent sets.

Design.—: The analytical performance of Tregs assay using reagent sets supplied by 3 manufacturers was evaluated after establishing the gating strategy and determining the optimal antibody concentration. Postcollection sample stability was evaluated, as well as the repeatability, reproducibility, reportable range, linearity, and assay carryover. Agreement between the different assays was assessed via Bland-Altman plots and linear regression analysis. The relationship between the frequency of CD4+CD25+CD127low/- Tregs and CD4+CD25+Foxp3+ Tregs was evaluated.

Results.—: The postcollection sample stability was set at 72 hours after collection at room temperature. The accuracy, repeatability, reproducibility, and accuracy all met the requirements for clinical analysis. Excellent linearity, with R2 ≥0.9 and no assay carryover, was observed. For reportable range, a minimum of 1000 events in the CD3+CD4+ gate was required for Tregs assay. Moreover, the results for Tregs labeled by antibodies from the 3 manufacturers were in good agreement. The percentage of CD4+CD25+CD127low/- Tregs was closely correlated with CD4+CD25+Foxp3+ Tregs.

Conclusions.—: This is the first study to evaluate systematically the measurement performance of Tregs in peripheral blood by flow cytometry, which provides a practical solution to verifying the performance of flow cytometry-based immune monitoring projects in clinical practice.